These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies. Reedman BM; Klein G; Pope JH; Walters MK; Hilgers J; Singh S; Johansson B Int J Cancer; 1974 Jun; 13(6):755-63. PubMed ID: 4136722 [No Abstract] [Full Text] [Related]
48. Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies. Huang DP; Ho JH; Henle W; Henle G Int J Cancer; 1974 Nov; 14(5):580-8. PubMed ID: 4142471 [No Abstract] [Full Text] [Related]
49. An established Burkitt's lymphoma line with cell membrane IgG. Klein E; Nilsson K; Yefenoff E Clin Immunol Immunopathol; 1975 Mar; 3(4):575-83. PubMed ID: 163717 [No Abstract] [Full Text] [Related]
50. Detection of Epstein-Barr virus-determined intracellular antigens in unfixed cells with labeled antibodies. Hilgers F; Rosén A; Lamon E; Klein G J Natl Cancer Inst; 1974 Oct; 53(4):949-55. PubMed ID: 4372371 [No Abstract] [Full Text] [Related]
51. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines. Sugawara K; Mizuno F; Osato T Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346 [No Abstract] [Full Text] [Related]
52. Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains. Dölken G; Klein G Virology; 1976 Mar; 70(1):210-3. PubMed ID: 176804 [No Abstract] [Full Text] [Related]
53. Solid-phase radioimmunoassays for Epstein-Barr virus associated antigens. Dölken G; Gier A; Finke J; Weitzmann U Ric Clin Lab; 1982; 12(1):307-12. PubMed ID: 6283618 [No Abstract] [Full Text] [Related]
54. Production of infective Epstein-Barr virus in a Burkitt lymphoma cell line, P3HR-1. Nagoya T; Hinuma Y Gan; 1972 Feb; 63(1):87-93. PubMed ID: 4339714 [No Abstract] [Full Text] [Related]
55. Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt's lymphoma. Comparison of dying patients with long-term survivors. Henle W; Henle G; Gunvén P; Klein G; Clifford P; Singh S J Natl Cancer Inst; 1973 May; 50(5):1163-73. PubMed ID: 4351392 [No Abstract] [Full Text] [Related]
56. Endemic and sporadic cases of Epstein-Barr virus-positive Burkitt's lymphoma: immunological characterization of derived cell lines. Rooney CM; Rowe M; Rickinson AB; Lenoir GM; Moss DM; Epstein MA Haematol Blood Transfus; 1985; 29():308-11. PubMed ID: 2993123 [No Abstract] [Full Text] [Related]
57. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide. Tanaka A; Nonoyama M; Hampar B Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800 [No Abstract] [Full Text] [Related]